Magstim published a randomized clinical trial published in JAMA Network Open exploring whether weekly maintenance transcranial magnetic stimulation (TMS) could help sustain improvement after a successful initial course.
Published
Signal category
Research & Knowledge
Quote
“A randomized clinical trial published in JAMA Network Open explored whether weekly maintenance transcranial magnetic stimulation (TMS) could help sustain improvement after a successful initial course.”
— Nicolas Hubacz, M.S.|Magstim team
Company
Magstim
Inspired Neurotechnology. The Brains Behind Transcranial Magnetic Stimulation TMS.
- Industry
- Medical Equipment Manufacturing
- Location
- Whitland, GB
- Company size
- 101 employees
Based in Wales, The Magstim Company Ltd is engaged in the research, development, manufacture and marketing of medical and research devices within the neurological and surgical fields. Through our products, we enable researchers and clinicians to assess, protect and improve the functioning of the nervous system in various applications. Our principal products are: Magstim (www.magstim.com) - a range of magnetic nerve stimulators Neurosign (www.neurosignsurgical.com) - a range of intra-operative nerve monitors (IONM)
Founded 1990